Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Multicenter evaluation of a novel ROS1 immunohistochemistry assay (SP384) for detection of ROS1 rearrangements in a large cohort of lung adenocarcinoma patients.

Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage AL, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette CH, Sabourin JC, Ilié M, Hofman P.

J Thorac Oncol. 2019 Apr 15. pii: S1556-0864(19)30283-7. doi: 10.1016/j.jtho.2019.03.024. [Epub ahead of print]

PMID:
30999109
2.

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?

Hofman P, Badoual C, Henderson F, Berland L, Hamila M, Long-Mira E, Lassalle S, Roussel H, Hofman V, Tartour E, Ilié M.

Cancers (Basel). 2019 Feb 27;11(3). pii: E283. doi: 10.3390/cancers11030283. Review.

3.

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors.

Berland L, Heeke S, Humbert O, Macocco A, Long-Mira E, Lassalle S, Lespinet-Fabre V, Lalvée S, Bordone O, Cohen C, Leroy S, Hofman V, Hofman P, Ilié M.

J Thorac Dis. 2019 Jan;11(Suppl 1):S71-S80. doi: 10.21037/jtd.2018.11.102. Review.

4.

[The age of artificial intelligence in lung cancer pathology: Between hope, gloom and perspectives].

Heeke S, Delingette H, Fanjat Y, Long-Mira E, Lassalle S, Hofman V, Benzaquen J, Marquette CH, Hofman P, Ilié M.

Ann Pathol. 2019 Apr;39(2):130-136. doi: 10.1016/j.annpat.2019.01.003. Epub 2019 Feb 13. French.

PMID:
30772062
5.

The Desire to Better Understand Older Adults with Solid Tumors to Improve Management: Assessment and Guided Interventions-The French PACA EST Cohort Experience.

Boulahssass R, Gonfrier S, Champigny N, Lassalle S, François E, Hofman P, Guerin O.

Cancers (Basel). 2019 Feb 7;11(2). pii: E192. doi: 10.3390/cancers11020192.

6.

Management of Invasive Squamous Cell Carcinomas of the Conjunctiva.

Santoni A, Thariat J, Maschi C, Herault J, Baillif S, Lassalle S, Peyrichon ML, Salleron J, Caujolle JP.

Am J Ophthalmol. 2019 Apr;200:1-9. doi: 10.1016/j.ajo.2018.11.024. Epub 2018 Dec 12.

PMID:
30552889
7.

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients.

Ilié M, Ngo-Mai M, Long-Mira E, Lassalle S, Butori C, Bence C, Hamila M, Hofman V, Hofman P.

J Vis Exp. 2018 Sep 25;(139). doi: 10.3791/58082.

PMID:
30320751
8.

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.

Ilié M, Beaulande M, Ben Hadj S, Chamorey E, Schiappa R, Long-Mira E, Lassalle S, Butori C, Cohen C, Leroy S, Guérin O, Mouroux J, Marquette CH, Pomerol JF, Erb G, Hofman V, Hofman P.

Cancers (Basel). 2018 Sep 13;10(9). pii: E326. doi: 10.3390/cancers10090326.

9.

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Washetine K, Heeke S, Bonnetaud C, Kara-Borni M, Ilié M, Lassalle S, Butori C, Long-Mira E, Marquette CH, Cohen C, Mouroux J, Selva E, Tanga V, Bence C, Félix JM, Gazoppi L, Skhiri T, Gormally E, Boucher P, Clément B, Dagher G, Hofman V, Hofman P.

Cancers (Basel). 2018 Jun 29;10(7). pii: E220. doi: 10.3390/cancers10070220.

10.

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

Washetine K, Kara-Borni M, Heeke S, Bonnetaud C, Félix JM, Ribeyre L, Bence C, Ilié M, Bordone O, Pedro M, Maitre P, Tanga V, Gormally E, Mossuz P, Lorimier P, Marquette CH, Mouroux J, Cohen C, Lassalle S, Long-Mira E, Clément B, Dagher G, Hofman V, Hofman P.

Cancers (Basel). 2018 Jun 11;10(6). pii: E195. doi: 10.3390/cancers10060195.

11.

[Focus on clinical and pathological management of conjunctival melanocytic tumors].

Lassalle S, Caujolle JP, Leger F, Maschi C, Gastaud L, Nahon-Esteve S, Thariat J, Baillif S, Hofman P.

Ann Pathol. 2018 Jun;38(3):153-163. doi: 10.1016/j.annpat.2018.03.006. Epub 2018 May 24. Review. French.

PMID:
29803361
12.

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Hofman V, Lassalle S, Bence C, Long-Mira E, Nahon-Estève S, Heeke S, Lespinet-Fabre V, Butori C, Ilié M, Hofman P.

Cancers (Basel). 2018 Mar 13;10(3). pii: E70. doi: 10.3390/cancers10030070. Review.

13.

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.

Ilie M, Butori C, Lassalle S, Heeke S, Piton N, Sabourin JC, Tanga V, Washetine K, Long-Mira E, Maitre P, Yazbeck N, Bordone O, Lespinet V, Leroy S, Cohen C, Mouroux J, Marquette CH, Hofman V, Hofman P.

Oncotarget. 2017 Oct 4;8(61):103055-103062. doi: 10.18632/oncotarget.21476. eCollection 2017 Nov 28.

14.

Erratum à l’article : « Immunohistochimie PD-1/PD-L1 en oncologie thoracique : où en sommes-nous ? » [Ann. Pathol. 37(1) (2017) 39–45].

Hofman P, Ilié M, Lassalle S, Long É, Coraline Bence, Butori C, Hofman V.

Ann Pathol. 2017 Aug;37(4):344. doi: 10.1016/j.annpat.2017.06.002. Epub 2017 Aug 1. French. No abstract available.

PMID:
28778623
15.

Inverted conjunctival papilloma: a certainly underestimated high-risk lesion for carcinomatous transformation-a case report.

Lassalle S, Maschi C, Caujolle JP, Giordanengo V, Hofman P.

Can J Ophthalmol. 2017 Feb;52(1):e30-e31. doi: 10.1016/j.jcjo.2016.08.003. Epub 2016 Nov 16. No abstract available.

PMID:
28237169
16.

[PD1/PD-L1 immunohistochemistry in thoracic oncology: Where are we?]

Hofman P, Ilié M, Lassalle S, Long E, Bence C, Butori C, Hofman V.

Ann Pathol. 2017 Feb;37(1):39-45. doi: 10.1016/j.annpat.2016.12.006. Epub 2017 Jan 31. French. Erratum in: Ann Pathol. 2017 Aug;37(4):344.

PMID:
28159404
17.

PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome.

Ilie M, Falk AT, Butori C, Chamorey E, Bonnetaud C, Long E, Lassalle S, Zahaf K, Vénissac N, Mouroux J, Cohen C, Brambilla E, Marquette CH, Hofman V, Hofman P.

Mod Pathol. 2016 Dec;29(12):1552-1564. doi: 10.1038/modpathol.2016.149. Epub 2016 Aug 26.

18.

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.

Lassalle S, Zangari J, Popa A, Ilie M, Hofman V, Long E, Patey M, Tissier F, Belléannée G, Trouette H, Catargi B, Peyrottes I, Sadoul JL, Bordone O, Bonnetaud C, Butori C, Bozec A, Guevara N, Santini J, Hénaoui IS, Lemaire G, Blanck O, Vielh P, Barbry P, Mari B, Brest P, Hofman P.

Oncotarget. 2016 May 24;7(21):30461-78. doi: 10.18632/oncotarget.8458.

19.

[Issues and current limits for immunohistochemical assessment of PD-L1 status in bronchial biopsies].

Hofman V, Ilie M, Long E, Butori C, Lassalle S, Washetine K, Lalve S, Marquette CH, Soria JC, Hofman P.

Bull Cancer. 2016 Apr;103(4):368-80. doi: 10.1016/j.bulcan.2016.01.014. Epub 2016 Feb 23. Review. French.

PMID:
26920041
20.

Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.

Ilie M, Long-Mira E, Funck-Brentano E, Lassalle S, Butori C, Lespinet-Fabre V, Bordone O, Gay A, Zahaf K, Poissonnet G, Lacour JP, Bahadoran P, Ballotti R, Gros A, Dutriaux C, Saiag P, Merlio JP, Vergier B, Emile JF, Hofman V, Hofman P.

J Am Acad Dermatol. 2015 May;72(5):786-93. doi: 10.1016/j.jaad.2015.01.012. Epub 2015 Feb 7.

PMID:
25659223

Supplemental Content

Loading ...
Support Center